2003•Unpublished venueRequires access

Process Validation of Pharmaceutical Ingredients

Robert A. Nash

Open publisher page 3 citations

Abstract

This chapter reviews the requirements of the U.S. Food and Drug Administration (FDA) for process validation of manufacturing pharmaceutical active ingredients (APIs) and inactive ingredients used in human and veterinary drug products.

About this research paper

What this paper is about

This chapter reviews the requirements of the U.S. Food and Drug Administration (FDA) for process validation of manufacturing pharmaceutical active ingredients (APIs) and inactive ingredients used in human and veterinary drug products.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter reviews the requirements of the U.S. Food and Drug Administration (FDA) for process validation of manufacturing pharmaceutical active ingredients (APIs) and inactive ingredients used in human and veterinary drug products.

Key concepts: Process validation, Process engineering, Process (computing), Computer science, Business, Engineering, New product development, Marketing

Related papers

Back to paper searchBrowse research topicsOriginal source
Process Validation of Pharmaceutical Ingredients — Research Paper | ScholarLens